NCT00636545 2012-04-06
Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors
Genta Incorporated
Phase 1 Completed
Clinical Trials
4 trialsNCT00518895 2011-11-07
AGENDA
Genta Incorporated
Phase 3 Completed
NCT00021749 2009-11-13
Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia
Genta Incorporated
Phase 1/2 Completed
NCT00543231 2007-10-12
A Phase I Study of G3139 Subcutaneous in Solid Tumors
Genta Incorporated
Phase 1 Completed